Predicting Durable Responses to Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer Using a Multi-Feature Model

Due to the complex mechanisms affecting anti-tumor immune response, a single biomarker is insufficient to identify patients who will benefit from immune checkpoint inhibitors (ICIs) treatment. Therefore, a comprehensive predictive model is urgently required to predict the response to ICIs. A total o...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Lei, Zhang, Hongbing, Pan, Chaohu, Yi, Jian, Cui, Xiaoli, Li, Na, Wang, Jiaqian, Gao, Zhibo, Wu, Dongfang, Chen, Jun, Jiang, Jizong, Chu, Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072668/
https://www.ncbi.nlm.nih.gov/pubmed/35529874
http://dx.doi.org/10.3389/fimmu.2022.829634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9072668/
https://www.ncbi.nlm.nih.gov/pubmed/35529874
http://dx.doi.org/10.3389/fimmu.2022.829634

Ejemplares similares